SKYRIZI® Gets Positive Reimbursement for UC in Canada
Canada's Drug Agency recommends SKYRIZI® for ulcerative colitis reimbursement, and AbbVie signs a Letter of Intent with the pCPA, improving access for 120,000 Canadians.
Canada's Drug Agency recommends SKYRIZI® for ulcerative colitis reimbursement, and AbbVie signs a Letter of Intent with the pCPA, improving access for 120,000 Canadians.